DENVER, April 13, 2018 -- Elixinol, a proud member of the US Hemp Roundtable, applauds the Hemp Farming Act Bill of 2018. Introduced on April 12, 2018, the bill is a bipartisan effort sponsored by Senator Mitch McConnell (R-Ky.) and co-sponsored by Sens. Ron Wyden (D-Ore.) and Rand Paul (R-Ky.). Jamie Comer (R-Ky.) is expected to introduce a House companion bill.
|
||||||||||
Elixinol has been sourcing hemp for its CBD hemp oil products from state-approved Colorado hemp farms for the last year.
The Hemp Farming Act of 2018 allows states and Native American tribes to regulate hemp growth within their jurisdictions. Further, it makes hemp research eligible for competitive grant funding at the USDA and further protects hemp farmers by making crop insurance available.
“To remove any federal ambiguity about hemp’s legality, support the US agricultural community and reinforce hemp’s place in research is a complete home-run for American consumers,” said Chris Husong, Elixinol Director.
“Because this bill has the potential to create tens of thousands of US jobs, provide Americans with more natural food, supplement and fiber choices and revolutionize wellness in the United States, it’s not going too far to say this is one of the most positive and economically impactful Senate bills we’ve seen in years,” continued Husong.
The Senate’s Hemp Farming Act Bill of 2018 will federally define hemp as having no more than .3% THC and as such, permanently remove it from the Controlled Substances Act, enabling hemp-based products, including food, to once again be household products.
“We are overjoyed by the decision to expedite the Hemp Farming Act through Congress. We, along with many partners have worked tirelessly to reinvigorate this industry in the US,” said Gabriel Ettenson Elixinol co-founder and General Manager.
“The exciting compounds within hemp have the power to transform the health of our society and move toward environmental sustainability,” he continued.
About Elixinol:
Colorado-based Elixinol, co-founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products in 40 countries globally including North and South America, throughout Europe, Asia and the Pacific Region. Elixinol’s parent company Elixinol Global (elixinolglobal.com) is publicly traded under EXL. More information available at Elixinol.com.
Photos accompanying this announcement are available at http://resource.globenewswire.com/Resource/Download/f92626e9-0cbc-43e5-9f4f-1a80f5eb6194
http://resource.globenewswire.com/Resource/Download/e5741502-72fa-4811-9e53-e6b284c7e0d1
Media Contact:
Chris Husong
Elixinol
+1 844-804-3504 ext 420
[email protected]


Trump Administration Plans New Drug Pricing Deals With Biotech Firms
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
Street Poller Media and The Boom of the Street Interview Ad Industry
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Amazon Secures 200 MW Wind Power Deals in Sweden
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
Google Expands Gemini Enterprise With AI Tools for Legal Sector
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 



